November 1, 2024: FDA Issues Warning To Patients Taking Compounded Semaglutide Drugs In October, the FDA issued a letter titled, FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. In the letter, the FDA warned people taking compounded versions of GLP-1 drugs for weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 165.Szopinska-Tokov J., Dam S., Naaijen J., Konstanti P., Rommelse N., Belzer C., Buitelaar J., Franke B., Bloemendaal M., Aarts E., et al
Studies that used these tests have shown that both short- and long-acting GLP1RAs decelerate the gastric emptying
Six months later, the pain has not returned and I am back to my regular workload without any issues
Patients can receive their injections at the office weekly or be taught self-administration of the treatment
Stay away from processed salts and processed sodium rich foods and consume natural foods, stick to a low-moderate carbohydrate, high good fat diet, and consume unprocessed sea salts and pink salts